Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
12,020
+670 (5.90%)
Jan 30, 2026, 3:30 PM KST
245.90% (1Y)
| Market Cap | 332.69B +231.6% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 199.21 |
| Forward PE | n/a |
| Dividend | 30.00 (0.26%) |
| Ex-Dividend Date | Mar 4, 2025 |
| Volume | 3,963,625 |
| Average Volume | 3,726,071 |
| Open | 11,250 |
| Previous Close | 11,350 |
| Day's Range | 11,060 - 13,150 |
| 52-Week Range | 2,995 - 14,700 |
| Beta | 0.55 |
| RSI | 63.69 |
| Earnings Date | n/a |